1. Home
  2. JDZG vs APLM Comparison

JDZG vs APLM Comparison

Compare JDZG & APLM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JDZG
  • APLM
  • Stock Information
  • Founded
  • JDZG 2020
  • APLM 2016
  • Country
  • JDZG China
  • APLM United States
  • Employees
  • JDZG N/A
  • APLM N/A
  • Industry
  • JDZG Other Consumer Services
  • APLM Blank Checks
  • Sector
  • JDZG Real Estate
  • APLM Finance
  • Exchange
  • JDZG Nasdaq
  • APLM Nasdaq
  • Market Cap
  • JDZG 5.7M
  • APLM 6.1M
  • IPO Year
  • JDZG 2024
  • APLM N/A
  • Fundamental
  • Price
  • JDZG $1.70
  • APLM $5.47
  • Analyst Decision
  • JDZG
  • APLM
  • Analyst Count
  • JDZG 0
  • APLM 0
  • Target Price
  • JDZG N/A
  • APLM N/A
  • AVG Volume (30 Days)
  • JDZG 129.9K
  • APLM 36.1K
  • Earning Date
  • JDZG 04-25-2025
  • APLM 09-19-2025
  • Dividend Yield
  • JDZG N/A
  • APLM N/A
  • EPS Growth
  • JDZG N/A
  • APLM N/A
  • EPS
  • JDZG 0.25
  • APLM N/A
  • Revenue
  • JDZG $2,567,741.00
  • APLM $198,000.00
  • Revenue This Year
  • JDZG N/A
  • APLM $415.15
  • Revenue Next Year
  • JDZG N/A
  • APLM N/A
  • P/E Ratio
  • JDZG $7.03
  • APLM N/A
  • Revenue Growth
  • JDZG 20.36
  • APLM N/A
  • 52 Week Low
  • JDZG $1.58
  • APLM $3.66
  • 52 Week High
  • JDZG $21.28
  • APLM $35.98
  • Technical
  • Relative Strength Index (RSI)
  • JDZG 38.83
  • APLM 50.10
  • Support Level
  • JDZG $1.71
  • APLM $3.66
  • Resistance Level
  • JDZG $2.13
  • APLM $6.37
  • Average True Range (ATR)
  • JDZG 0.15
  • APLM 0.59
  • MACD
  • JDZG 0.02
  • APLM -0.01
  • Stochastic Oscillator
  • JDZG 10.40
  • APLM 66.80

About JDZG JIADE LIMITED Common stock

Jiade Ltd specializes in providing one-stop comprehensive education supporting services to adult education institutions, through a wide range of software platform and auxiliary solutions. Auxiliary solutions encompass exam administration services and teaching support services throughout the entire teaching cycle. Specifically, the company offers pre-enrollment guidance on school/major selection and application strategy development, training for entrance exams, and assistance in the application process. The company also provides offline tutoring, exam administration services, guidance on graduation thesis, and social practice assistance included in the one-stop comprehensive education supporting services in the People's Republic of China.

About APLM Apollomics Inc.

Apollomics Inc is an clinical-stage biopharmaceutical company focused on the discovery and development of oncology therapies with the potential to be combined with other treatment options to harness the immune system and target specific molecular pathways to inhibit cancer. The company programs include vebreltinib (APL-101), a potent, selective c-Met inhibitor for the treatment of non-small cell lung cancer and other tumors with c-Met alterations, and uproleselan (APL-106), a specific E-Selectin antagonist that has the potential to be used adjunctively with standard chemotherapy to treat acute myeloid leukemia.

Share on Social Networks: